https://priavoid.com/ 2026-03-16T14:22:56+00:00 https://priavoid.com/team-management/ 2026-03-12T22:26:20+00:00 https://priavoid.com/cookie-policy/ 2022-07-14T18:40:52+00:00 https://priavoid.com/privacy/ 2026-03-12T23:47:05+00:00 https://priavoid.com/imprint/ 2026-03-12T23:46:02+00:00 https://priavoid.com/partnering/ 2026-03-16T13:40:38+00:00 https://priavoid.com/pipeline/ 2026-03-16T12:27:27+00:00 https://priavoid.com/platform/ 2026-03-16T10:28:54+00:00 https://priavoid.com/team-scientific-advisory/ 2025-07-18T07:21:04+00:00 https://priavoid.com/team-supervisory/ 2025-11-03T10:48:44+00:00 https://priavoid.com/about-us/ 2026-03-16T10:27:44+00:00 https://priavoid.com/contact/ 2026-03-14T01:37:50+00:00 https://priavoid.com/media/ 2026-03-16T10:36:13+00:00 https://priavoid.com/2026/03/19/priavoid-presents-preclinical-poc-for-pri-101-at-adpd2026/ 2026-03-19T09:04:46+00:00 https://priavoid.com/2026/03/17/priavoid-presents-initial-phase-2-data-suggesting-favorable-safety-profile-for-alzheimers-candidate-at-adpd2026/ 2026-03-17T10:16:49+00:00 https://priavoid.com/2026/03/05/priavoid-presents-initial-phase-2-data-at-adpd2026/ 2026-03-17T10:55:56+00:00 https://priavoid.com/2026/03/03/bio-europe-spring-lisbon-23-25-march/ 2026-03-16T10:03:05+00:00 https://priavoid.com/2026/03/03/ad-pd-2026-copenhagen-17-21-march/ 2026-03-17T10:57:19+00:00 https://priavoid.com/2025/07/17/priavoid-appoints-cso-and-cmo/ 2025-07-17T08:59:33+00:00 https://priavoid.com/2025/02/26/primus-ad-recruitment-for-phase-ii-clinical-trial-of-alzheimers-drug-pri-002-successfully-completed/ 2025-02-26T10:24:24+00:00 https://priavoid.com/2024/10/01/priavoid-receives-funding-from-the-alzheimers-association-and-the-rainwater-charitable-foundation/ 2024-10-01T14:53:04+00:00 https://priavoid.com/2023/11/20/new-alzheimers-drug-pri-002-receives-ema-approval-for-phase-ii-study/ 2023-11-20T09:39:50+00:00 https://priavoid.com/2022/08/12/priavoid-selected-to-german-accelerator-program/ 2022-08-12T12:14:56+00:00 https://priavoid.com/2021/02/24/priavoid-and-forschungszentrum-juelich-receive-funding-from-the-michael-j-fox-foundation/ 2023-11-20T09:41:10+00:00 https://priavoid.com/2021/02/12/priavoid-closes-financing-round/ 2023-11-20T09:41:10+00:00 https://priavoid.com/2021/02/04/alzheimers-research-important-milestone-for-pri-002/ 2023-11-20T09:41:10+00:00 https://priavoid.com/2020/12/17/priavoid-headquarters-at-life-science-center-dusseldorf/ 2023-11-20T09:41:10+00:00 https://priavoid.com/2020/12/09/nobel-prize-winner-stanley-prusiner-joins-priavoids-supervisory-board/ 2023-11-20T09:41:10+00:00 https://priavoid.com/2020/09/01/philipp-buerling-appointed-ceo-of-priavoid/ 2023-11-20T09:41:10+00:00